BioMEMS Diagnostics has filed a notice of an exempt offering of securities to raise $3,000,000.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, BioMEMS Diagnostics is raising $3,000,000.00 in new funding. Sources indicate as part of senior management President and Chief Executive Officer, Casey Fowler played a key…